Highly accomplished management team, consultants, board of directors and advisors that provide vision and leadership in the science, technology and financial aspects of the business.
Proprietary genomic analytics pioneered through 15,000 case studies by one of the world’s leading geneticists whose previous research collaboration was short-listed for the Nobel Prize in medicine.
Generative AI Platform Insights derived from the analytics have been programmed into a scalable generative AI machine learning platform called GEDI (Genomics Empowered Digitized Identity).
Quantum Computing GEDI will integrate with IBM’s world leading quantum computing platform to innovate in the fields of drug discovery and development, and in-silico clinical trials.